This is eye opening to me. I am very happy you are posting your thoughts on this. It makes total sense.
Go Leo & Brilacidin!
That is correct. Russia’s SOC is different then in our US hospitals.
So this can be Huge on multiple levels since if Brilacidin can Show synergistic value both with our local US Standard of Care and also with the Overseas SOC, we can see huge $’s in my opinion since Remdesivir is widely only being used in the US as SOC and you can see they brought in billions last year.